Kirkland Signature Did $90 Billion Last Year.

That Makes It Bigger Than Procter & Gamble.

Costco reported at its 2026 shareholder meeting that Kirkland Signature generated $90 billion in sales last year. To put that number in context: Nestlé, the largest CPG company on earth, did roughly $114 billion. PepsiCo did $94 billion. Procter & Gamble did $84 billion. If Kirkland Signature were a standalone company, it would be bigger than the company that makes Tide, Pampers, and Gillette.

A store brand. Sold in a warehouse. With virtually no traditional media spend.

That’s not a private label success story. That’s a structural break in how the CPG value chain works. For decades, the model was clear: brands innovated and built consumer relationships, retailers provided distribution and shelf space. The brand was the product. The retailer was the infrastructure. Kirkland Signature flips that entirely — the retailer is the brand, and the brand is the product. And at $90 billion, it’s not an experiment. It’s the new reality.

The scope is what should concern CPG executives most. Kirkland isn’t winning in one or two categories. It spans vodka, diapers, olive oil, batteries, laundry detergent, coffee, vitamins - every aisle, every occasion. Kirkland diapers are made by Kimberly-Clark, the same manufacturer behind Huggies. The olive oil meets the same sourcing standards as premium Italian brands. The quality gap that used to justify national brand pricing has effectively closed, and consumers know it.

And the numbers say they’re choosing accordingly. Costco topped Caliber’s 2026 U.S. Trust & Like Poll, dethroning Amazon, with a score of 79, up year-over-year at a time when tariff anxiety crushed consumer confidence and Target fell three points. Circana’s data shows U.S. private label sales crossed $330 billion total, with Gen Z adoption on pace to surpass boomers by mid-2026. The generation that was supposed to be brand-obsessed is choosing the warehouse club label. At this point, Kirkland isn’t private label. It’s the label.

The question I keep coming back to is what it actually means when a retailer’s house brand out-revenues P&G. Brand equity still gets talked about in most boardrooms like it’s a permanent asset; something accumulated over decades that compounds on its own. But it doesn’t. It erodes the moment you stop earning it. And the information asymmetry that used to protect it collapsed the moment someone could Google “who makes Kirkland diapers” in the aisle and find out it’s Kimberly-Clark. When Kirkland offers comparable quality at a lower price, under a name that 147 million cardholders trust enough to renew at a 92.3% rate, the old moat doesn’t drain slowly. It just stops being a moat.

I don’t think the answer for national brands is trying to out-Kirkland Kirkland. You’re not going to beat a $90 billion private label on price or breadth. But Kirkland’s dominance has a boundary: it wins in categories where the quality gap has closed and the purchase decision comes down to trust and value. In categories where genuine differentiation exists (specialty nutrition, clinical skincare, performance formulations, etc.), the brand still owns the relationship. The answer is figuring out what a dedicated brand can offer that a retailer’s label fundamentally can’t. Genuine product innovation that pushes categories forward, not line extensions that rearrange what already exists.

The tools exist. Real-time consumer sensing and scraped demand signals can spot unmet needs before a retailer’s buying team reacts. Generative AI is compressing product development timelines, reformulation at scale, rapid sensory optimization, computational flavor and fragrance design. Pipelines that used to take years can move in months; First-party data and DTC channels can build a consumer relationship that doesn’t depend on shelf position at all. And this isn’t theoretical. The two companies still ahead of Kirkland in the revenue rankings are the ones already moving this way: Nestlé compressed its product ideation cycle from six months to six weeks, and PepsiCo’s PepGenX platform achieved similar gains across its development pipeline. It’s not a coincidence that the CPG companies Kirkland hasn’t caught yet are the ones investing most aggressively in innovation speed.

But here’s the part most companies haven’t solved (and why generative AI hasn’t yet the silver bullet), that kind of innovation velocity requires R&D, marketing, supply chain, and commercial teams to operate as one system, not four functions that hand work to each other over the wall. The technology to move faster exists. The cross-functional orchestration to actually use it - Insight to formulation to shelf in a single, coordinated motion is what most CPG organizations still aren’t wired for. That’s the real gap. Not the tools. The operating model.